Business Wire - Merck Announces US Label Change for SINGULAIR® : New Growth Data in Children; Clinical Study Shows Children Taking SINGULAIR Maintained Similar Growth…
Monday, September 8th, 2008WHITEHOUSE STATION, N.J. — Merck & Co., Inc. today announced changes to the product label for SINGULAIR(R) (montelukast sodium), which includes new information from a 56-week clinical study that demonstrated that child…
